At the 35 min mark of this April webinar is the cryo-vacc update.
Also from the 33 min mark Stef highlights recent Nasdaq IPO's for similar types of companies to Renergen with ebitda for projects to kick in the 2027-2029 timeframe are trading at x7 to x14 the forward ebitda projections. So similar to Renergen with Phase 2 ebitda not to kick in fully till the 2026-2027 time-frame..
Renergen at lets say AUD200m marketcap versus the March Phase 2 guidance note of ebitda of AUD500m/yr equates to only a x0.4 forward ebitda multiple..
x7 to x 14 range would be AUD3.5b to a AUD7b marketcap..
RLT CHART, page-3118
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.83M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 08/08/2024 (20 minute delay) ? |
| RLT (ASX) Chart |
Day chart unavailable